Cargando…
Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line
We previously demonstrated that a differentiation inducing drug, vesnarinone induced the growth arrest and p21(waf1) gene expression in a human salivary gland cancer cell line, TYS. In the present study, we investigated the mechanism of the induction of p21(waf1) gene by vesnarinone in TYS cells. We...
Autores principales: | Omotehara, F, Kawamata, H, Uchida, D, Hino, S, Nakashiro, K, Fujimori, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364327/ https://www.ncbi.nlm.nih.gov/pubmed/12434298 http://dx.doi.org/10.1038/sj.bjc.6600592 |
Ejemplares similares
-
Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
por: Kawamata, H., et al.
Publicado: (1998) -
Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines
por: Uchida, D, et al.
Publicado: (2001) -
Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells
por: Liu, X M, et al.
Publicado: (2003) -
Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients
por: Kawamata, H, et al.
Publicado: (1999) -
A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells
por: Gong, Y, et al.
Publicado: (2002)